These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Systemic and renal haemodynamic effects of angiotensin converting enzyme inhibition by zabicipril in young and in old normal men. Naeije R; Fiasse A; Carlier E; Opsomer M; Leeman M Eur J Clin Pharmacol; 1993; 44(1):35-9. PubMed ID: 8436152 [TBL] [Abstract][Full Text] [Related]
3. Systemic, regional and cerebral hemodynamic effects of a new angiotensin converting enzyme inhibitor, imidapril, in healthy volunteers. Démolis P; Annane D; Duhazé P; Giudicelli JF Fundam Clin Pharmacol; 1994; 8(1):80-9. PubMed ID: 8181800 [TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic, pharmacokinetic and humoral effects of oral zabicipril, an angiotensin converting enzyme inhibitor in normotensive man. MacDonald NJ; Hughes DM; Lees KR; Reid JL Br J Clin Pharmacol; 1990 Jul; 30(1):107-13. PubMed ID: 2202384 [TBL] [Abstract][Full Text] [Related]
5. Cardiac and vascular effects of chronic angiotensin converting enzyme inhibition at subantihypertensive doses. Gohlke P; Stoll M; Lamberty V; Mattfeld T; Mall G; van Even P; Martorana P; Unger T J Hypertens Suppl; 1992 Aug; 10(6):S141-4. PubMed ID: 1432317 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, converting enzyme inhibition and peripheral arterial hemodynamics of ramipril in healthy volunteers. Thuillez C; Richer C; Giudicelli JF Am J Cardiol; 1987 Apr; 59(10):38D-44D. PubMed ID: 3034032 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic-pharmacodynamic model relating zabiciprilat plasma concentrations to brachial and femoral haemodynamic effects in normotensive volunteers. Bellissant E; Giudicelli JF Br J Clin Pharmacol; 1998 Oct; 46(4):383-93. PubMed ID: 9803988 [TBL] [Abstract][Full Text] [Related]
8. Noninvasive assessment of regional arteriolar and arterial dilating properties of lisinopril in healthy volunteers. Bellissant E; Thuillez C; Richer C; Pussard E; Giudicelli JF J Cardiovasc Pharmacol; 1994 Sep; 24(3):500-8. PubMed ID: 7528307 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin converting enzyme inhibition. Systemic and regional hemodynamics in rats and humans. Giudicelli JF; Richer C; Richard C; Thuillez C Am J Hypertens; 1991 Mar; 4(3 Pt 2):258S-262S. PubMed ID: 2043315 [TBL] [Abstract][Full Text] [Related]
11. Non invasive study of systemic and regional haemodynamic and cardiac effects of a new calcium antagonist, SR 33557, in healthy volunteers. Bellissant E; Thuillez C; Kechrid R; Duhaze P; Giudicelli JF Eur J Clin Pharmacol; 1991; 41(4):329-34. PubMed ID: 1804649 [TBL] [Abstract][Full Text] [Related]
12. Enzyme immunoassays for a new angiotensin-converting enzyme inhibitor, zabicipril, and its active metabolite in human plasma: application to pharmacokinetic studies. Ezan E; Morge X; Lelièvre E; Créminon C; Piraube C; Grognet JM Ther Drug Monit; 1993 Oct; 15(5):448-54. PubMed ID: 8249053 [TBL] [Abstract][Full Text] [Related]
13. [Peripheral hemodynamic and biological effects of perindopril in the healthy subject. Dose-effect relationship]. Richer C; Thuillez C; Desmichels D; Giudicelli JF Arch Mal Coeur Vaiss; 1986 Jun; 79(6):913-8. PubMed ID: 3026273 [TBL] [Abstract][Full Text] [Related]
15. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283 [TBL] [Abstract][Full Text] [Related]
16. Effects of an angiotensin converting enzyme inhibitor, ramipril, on intracranial circulation in healthy volunteers. off. Demolis P; Chalon S; Annane D; Duhaze P; Giudicelli JF Br J Clin Pharmacol; 1992 Sep; 34(3):224-30. PubMed ID: 1327051 [TBL] [Abstract][Full Text] [Related]
17. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure]. Mitrovic V; Mudra H; Bonzel T; Schmidt W; Schlepper M Z Kardiol; 1996 Nov; 85(11):828-38. PubMed ID: 9064945 [TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic effects of dual neutral endopeptidase-angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humans. Massien C; Azizi M; Guyene TT; Vesterqvist O; Mangold B; Ménard J Clin Pharmacol Ther; 1999 Apr; 65(4):448-59. PubMed ID: 10223783 [TBL] [Abstract][Full Text] [Related]
19. Systemic circulatory adjustments to acute hypoxia and reoxygenation in unanesthetized sheep. Role of renin, angiotensin II, and catecholamine interactions. Davidson D; Stalcup SA J Clin Invest; 1984 Feb; 73(2):317-28. PubMed ID: 6365971 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of dilevalol and propranolol on systemic and regional haemodynamics in healthy volunteers at rest and during exercise. Bellissant E; Annane D; Thuillez C; Giudicelli JF Eur J Clin Pharmacol; 1994; 47(1):39-47. PubMed ID: 7988622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]